Abstract:Background: Daunorubicin is a traditional chemotherapeutic agent that plays a pivotal role in leukemia therapy. However, the dose-related toxicity remains a considerable challenge. The apoptosis-regulating gene, PDCD5, is downregulated in various tumors, including leukemias, and may provide a potential target for the diagnosis and treatment of leukemia. The purpose of this study was to construct a triple-regulated oncolytic adenovirus carrying a PDCD5 gene expression cassette (SG611-PDCD5) and explore the combined antitumor efficacy of SG611-PDCD5 in combination with low dose daunorubicin on leukemic cells. Materials and methods: A variety of leukemic cell lines, including K.562, MEG-01, KG-1a, HL-60, SUP-B15, and BV-173, were cultured according to the providers' instructions. The insertion and orientation of all recombined plasmids were confirmed by restriction enzyme digestion and PCR. The tumor-selective replication of the constructed conditionally replicating SG611-PDCD5 and its antitumor efficacy in combination with daunorubicin were characterized in leukemic cell lines in vitro and in a nude mouse xenograft model. Cell viability was detected using cell-counting kit-8. Apoptosis was detected in whole living cells using flow cytometry and in paraffin-embedded tumor tissues using a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Results: The triple-regulated CRAd carrying SG611-PDCD5 and nude mouse xenograft models of K562 cells were successfully constructed. In vitro treatment with SG611-PDCD5 in combination with low-dose daunorubicin elicited more potent anti-proliferative and proapoptotic effects in leukemic cells in a dose-dependent manner. The Chou-Talalay analysis revealed synergistic anti-proliferative effects in all of the above cell lines. In the nude mice xenograft model, the tumor size in the control, daunorubicin, SG611-PDCD5, and combined treatment groups on day 10 were 170.1 +/- 47.8, 111.9 +/- 81.1, 60.7 +/- 12.3, and 33.2 +/- 17.5 mm(3), respectively (all P<0.05). The results of the TUNEL assay showed significantly more apoptotic cells in the SG611-PDCD5 plus daunorubicin group than in the SG611-PDCD5 or daunorubicin groups alone (25 +/- 0.82, 12.5 +/- 2.27, and 7.8 +/- 2.67 apoptotic cells/field, respectively) (P<0.05). Conclusion: The findings suggest that combined treatment with SG611-PDCD5 and daunorubicin may be a promising strategy for enhancing chemosensitivity and thus lowering the dose-related toxicity of daunorubicin in leukemia therapy.

Recombinant Human Programmed Cell Death 5 Combined with Doxorubicin Induced Apoptosis of Ewing Sarcoma in Vitro

Potent Antitumor Activities of Recombinant Human PDCD5 Protein in Combination with Chemotherapy Drugs in K562 Cells.

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Recombinant Human PDCD5 Protein Enhances Chemosensitivities of Hematologic Malignancies

Sensitizing effect of recombinant human PDCD5 protein on chemotherapy of acute monocytic leukemia cell line U937 and its mechanism]

Recombinant Human PDCD5 Sensitizes Chondrosarcomas to Cisplatin Chemotherapy in Vitro and in Vivo

Recombinant Human PDCD5 Protein Enhances Chemosensitivity of Breast Cancer in Vitro and in Vivo.

[In Vitro Antitumor Immune Response Induced by Fusion of Dendritic Cells and Ewing's Sarcoma Cells].

Adenovirus-Delivered Pdcd5 Counteracts Adriamycin Resistance of Osteosarcoma Cells Through Enhancing Apoptosis and Inhibiting Pgp

Short Interfering RNA Against the PDCD5 Attenuates Cell Apoptosis and Caspase-3 Activity Induced by Bax Overexpression

Adenovirus-mediated PDCD5 Gene Transfer Sensitizes K562 Cells to Apoptosis Induced by Idarubicin in Vitro and in Vivo

Synergistic Antitumoral Efficacy of a Novel Replicative Adenovirus SG611-PDCD5 and Daunorubicin in Human Leukemic Cells

Transfection of PDCD5 Effect on the Biological Behavior of Tumor Cells and Sensitized Gastric Cancer Cells to Cisplatin-Induced Apoptosis

Arsenic Trioxide as an Inducer of Apoptosis and Down-regulation of EWS-FLi1 Fusion Protein in Ewing Sarcoma

Experimental studies on paclitaxel - induced apoptosis and growth inhibitory effects in Ewing sarcoma cell line of RD-ES in Vitro

PDCD10 Promotes Proliferation, Migration, and Invasion of Osteosarcoma by Inhibiting Apoptosis and Activating EMT Pathway

A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines

Cellular Uptake of Exogenous Human PDCD5 Protein

Benzochloroporphyrin derivative photosensitizer-mediated photodynamic therapy for Ewing sarcoma.

[Adenovirus-Mediated PDCD5 Gene Transfer Sensitizes Apoptosis of K562 Cells Induced by Etoposide].

Synergistic Killing Effect of the Conditionally Replicating Adenoviruses Carrying Programmed Cell Death 5 Gene and Etoposide on K562 Cells